This is a StreetInsider.com Premium Only Page

(ALLO) –

Apr 24, 2024 04:19 PM Form 4 Allogene Therapeutics, For: Apr 22 Filed by: MOORE TIMOTHY L.

Apr 23, 2024 04:34 PM Form ARS Allogene Therapeutics, For: Dec 31

Apr 23, 2024 04:33 PM Form DEF 14A Allogene Therapeutics, For: Jun 05

Apr 23, 2024 04:33 PM Form DEFA14A Allogene Therapeutics,

Apr 22, 2024 04:10 PM Form 144 Allogene Therapeutics, Filed by: MOORE TIMOTHY L.

Apr 9, 2024 08:30 AM Allogene Therapeutics Announces Q2 Investor Conference Participation

Mar 18, 2024 08:11 PM Form 4 Allogene Therapeutics, For: Mar 14 Filed by: Chang David D

Mar 14, 2024 05:29 PM Form S-8 Allogene Therapeutics,

Mar 14, 2024 05:23 PM Allogene Therapeutics (ALLO) Files $500M Mixed Shelf

Mar 14, 2024 05:21 PM Form S-3 Allogene Therapeutics,

Mar 14, 2024 04:56 PM Form 10-K Allogene Therapeutics, For: Dec 31

Mar 14, 2024 04:53 PM Allogene Therapeutics, Inc. (ALLO) Misses Q4 EPS by 6c

Mar 14, 2024 04:52 PM Form POSASR Allogene Therapeutics,

Mar 14, 2024 04:32 PM Form 144 Allogene Therapeutics, Filed by: Chang David D

Mar 14, 2024 04:11 PM Form 8-K Allogene Therapeutics, For: Mar 14

Mar 14, 2024 04:05 PM Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

Mar 14, 2024 04:02 PM Form 10-K/A Allogene Therapeutics, For: Dec 31

Mar 12, 2024 08:30 AM Allogene Therapeutics (ALLO) and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement

Mar 12, 2024 08:30 AM Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease

Mar 6, 2024 09:52 PM Form 4 Allogene Therapeutics, For: Jan 30 Filed by: Parker Geoffrey M.

Mar 5, 2024 08:30 AM Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update

Feb 28, 2024 08:30 AM Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference

Feb 27, 2024 08:35 AM Allogene (ALLO) PT Lowered to $8 at JPMorgan

Feb 16, 2024 08:31 AM Form 8-K Allogene Therapeutics, For: Feb 14

Feb 16, 2024 08:30 AM Allogene Therapeutics (ALLO) to Restate Previously Filed Financial Statements

Feb 16, 2024 08:30 AM Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Ventur

Feb 14, 2024 04:36 PM Form SC 13G/A Allogene Therapeutics, Filed by: Belldegrun Arie

Feb 14, 2024 04:32 PM Form SC 13G/A Allogene Therapeutics, Filed by: Chang David D

Feb 13, 2024 05:01 PM Form SC 13G/A Allogene Therapeutics, Filed by: VANGUARD GROUP INC

Feb 9, 2024 08:37 AM Form SC 13G/A Allogene Therapeutics, Filed by: FMR LLC

Jan 31, 2024 05:52 PM Form 4 Allogene Therapeutics, For: Jan 25 Filed by: MOORE TIMOTHY L.

Jan 31, 2024 05:49 PM Form 4 Allogene Therapeutics, For: Jan 25 Filed by: Douglas Earl Martin

Jan 31, 2024 05:48 PM Form 4 Allogene Therapeutics, For: Jan 25 Filed by: Parker Geoffrey M.

Jan 31, 2024 05:47 PM Form 4 Allogene Therapeutics, For: Jan 25 Filed by: Belldegrun Arie

Jan 31, 2024 05:46 PM Form 4 Allogene Therapeutics, For: Jan 25 Filed by: Roberts Zachary

Jan 31, 2024 05:42 PM Form 4 Allogene Therapeutics, For: Jan 25 Filed by: Chang David D

Jan 31, 2024 06:16 AM Allogene Therapeutics (ALLO) Enters Amended and Restated Collaboration and License Agreement with Notch Therapeutics

Jan 31, 2024 06:05 AM Form 8-K Allogene Therapeutics, For: Jan 25

Jan 29, 2024 05:26 PM Form SC 13G/A Allogene Therapeutics, Filed by: BlackRock Inc.

Jan 24, 2024 05:26 PM Form 4 Allogene Therapeutics, For: Jan 22 Filed by: Roberts Zachary

Jan 23, 2024 10:02 AM Form SC 13G/A Allogene Therapeutics, Filed by: STATE STREET CORP

Jan 22, 2024 04:12 PM Form 144 Allogene Therapeutics, Filed by: Roberts Zachary

Jan 19, 2024 06:43 AM Allogene (ALLO) PT Lowered to $10 at H.C. Wainwright

Jan 16, 2024 04:05 PM Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

Jan 8, 2024 07:20 AM Allogene (ALLO) PT Lowered to $17 at Truist Securities

Jan 5, 2024 09:16 AM Allogene Therapeutics (ALLO) shares plunge, company announces 22% workforce reduction

Jan 5, 2024 08:04 AM Allogene (ALLO) PT Lowered to $10 at B.Riley

Jan 5, 2024 08:01 AM Form 8-K Allogene Therapeutics, For: Jan 03

Jan 5, 2024 06:11 AM Guggenheim Downgrades Allogene (ALLO) to Neutral

Jan 5, 2024 02:23 AM JMP Securities Downgrades Allogene (ALLO) to Market Perform